drugset / Trial / NCT00426608

To Investigate Effects GSK561679 on Part of the Body's System That Controls the Balance of Many of the Hormones.

NCT00426608

Phase 1 Completed 20 enrolled GlaxoSmithKline
RandomizedCrossoverDiagnostic

Summary

A study to investigate the effects GSK561679 on part of the body's system that controls the balance of many of the hormones (including cortisol).

Timeline

Start
2006-10-06
Primary completion
2007-01-08
Completion
2007-01-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Alprazolam Small molecule 0.25 mg
Subject VERUCERFONT Small molecule 10 mg
Subject VERUCERFONT Small molecule 50 mg
Subject VERUCERFONT Small molecule 200 mg
Subject VERUCERFONT Small molecule 400 mg
Background Metyrapone Small molecule 0.04 g/kg

Indications

No indication recorded.